Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 26 Apr 2023
The dreaded hay fever signs, including itchy eyes, sneezing, and a stuffy nose, have arrived for many people with the arrival of spring. Up to 42% of people experience hay fever, making it a widespread condition. Immune system overreaction is the cause of it.
Read Full Newsvan Ingen, of Radboud University Medical Center discusses data showing add-on ALIS improved durable culture conversion in newly diagnosed MAC lung disease.
van Ingen, of Radboud University Medical Center, discusses the ENCORE trial's patient-reported endpoint for ALIS in MAC lung disease.
Vogelmeier, of Philipps-University of Marburg discusses pooled data showing reduced COPD exacerbations, though most effectively in former smokers.
Examining the Oral Steroid Burden in Asthma and COPD
Short Telomeres Linked to UIP Pattern, Not Fibrosis Extent, in ILD
CHEST 2026: Day 2 Recap — 4 Headlines to Know
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is biomarkers in multiple sclerosis!
1.
MCh in Surgical Oncology: Admission, Medical School, Fees, Qualifications Information
2.
Blood Cancer's First New Drug in 29 Years; AI for Mammography? Phase III Myeloma Win
3.
ASCO Future Focus: Follicular Lymphoma: Future Focus from the American Society of Clinical Onology
4.
There is a 40% reduction in the risk of 9 cancers with good cardiorespiratory fitness.
5.
WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research
1.
ERASur: Evaluating Total Ablative Therapy in Limited Metastatic Colorectal Cancer
2.
Strategic Solutions in Oncology for Modern Medicine
3.
Tumor Microenvironment Mapping in Cancer Care
4.
Malignant Prolactinoma: Prolactin Surge with Minimal Growth Masks Widespread Metastases
5.
Emerging Therapies Using Tumor Evolution Interruption Technologies
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
2.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
3.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
5.
Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge